Close
DONATE

Dr. John Greden to discuss GeneSight study results at upcoming APA annual meeting in May 2018

Nov. 02, 2017 — Myriad Announces GeneSight® Psychotropic Results from a Large Prospective Trial in Patients with Major Depressive Disorder

“From a clinician’s perspective, better but not well is not good enough and significant improvements in response and remission are always the most-desired endpoints,” said John Greden, M.D., Founding Chair of the National Network of Depression Centers (NNDC). “We are eager to discuss complete results from this study as well as potential future applications of pharmacogenomics at the upcoming APA annual meeting in May 2018.”

 

Read more

 

Categories: Education

The National Network of Depression Centers (NNDC) was established in 2008 to mobilize collaborative expertise to counteract the public health crisis of depression, bipolar illnesses, and other mood disorders. The NNDC is a nonprofit network of academic medical centers dedicated to improving the lives of those affected by depression and related mood disorders. We are working to change the national conversation surrounding these illnesses through large-scale collaborative studies, education and outreach.

For questions, please email [email protected]

If you or someone else has a medical or mental health emergency or requires immediate assistance dial 911.

If you are experiencing a suicidal, substance use, and/or mental health crisis, or any other kind of emotional distress, or if you are worried about someone who may need crisis support dial 988.

National Network of Depression Centers © 2024 All Rights Reserved. Privacy Policy